Answers are grounded in this paper and cite their sources.
Purpose To evaluate the technical feasibility, hemodynamic effects, and early clinical outcomes of the 6–10 mm GORE VIATORR TIPS Endoprosthesis with Controlled Expansion, which extends the prior 8 mm deployment floor to 6 mm. Materials and Methods This single-center retrospective study included consecutive patients who underwent de novo transjugular intrahepatic portosystemic shunt (TIPS) creation with the 6–10 mm device between April and July 2026. Technical success was defined as portosystemic pressure gradient (PSPG) below 12 mmHg or ≥ 50% reduction from baseline. Result Twelve patients (8 females, 4 males; mean age 57.1 ± 15.7 years; range 32–83 years) were included. Indications for TIPS creation were variceal hemorrhage (50.0%; n = 6/12), refractory ascites (33.3%; n = 4/12), and refractory hepatic hydrothorax (16.7%; n = 2/12). Final stent diameter was less than 8 mm in 91.7% ( n = 11/12) of patients. Technical success was achieved in all patients, with mean PSPG decreasing from 16.7 ± 7.7 to 7.7 ± 2.9 mmHg ( P < .001) and no immediate adverse events. Shunt patency was 100% at short imaging follow-up (mean, 35.6 ± 25.0 days), with no reinterventions. No recurrent variceal hemorrhage occurred, and ascites improved or resolved in 77.8% ( n = 7/9) of patients at short clinical follow-up (mean, 50.5 ± 23.3 days). Four of 11 patients (36.4%) experienced symptomatic HE after TIPS creation and one patient (9.1%) died during the follow-up period. Conclusion TIPS creation using the 6–10 mm device is a technically feasible strategy with adequate short-term hemodynamic response.
No takes yet. Share an insight, caveat, or question.
Cyphers et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: